Safety and Efficacy of Rotational Atherectomy (RA) in Coronary Dissection

NCT ID: NCT01701596

Last Updated: 2014-08-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1/PHASE2

Total Enrollment

198 participants

Study Classification

INTERVENTIONAL

Study Start Date

2004-08-31

Study Completion Date

2013-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is aimed at examining the safety and efficacy of rotational atherectomy (RA) in nondilatable calcified lesion complicated by coronary dissection during percutaneous coronary intervention (PCI) procedure.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Coronary artery dissection is a contraindication for the use of rotational atherectomy, since rotational atherectomy may propagate coronary dissection. In the presence of coronary dissection, conservative management is suggested for approximately 4 weeks to permit the dissection to heal prior to treatment with rotational atherectomy. However, a lot of patients have frequent angina attacks and some patients develop serious complications including abrupt vessel closure during this period. Thus, immediate strategies cope with coronary dissection induced by balloon dilation is needed for the early recovery of those patients. The present study was performed to compare the safety and efficacy of immediate RA and delayed RA in the treatment with nondilatable calcified lesion complicated by coronary dissection.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Artery Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Rotational atherectomy (RA)

Immediate rotational atherectomy (RA) in the treatment with nondilatable calcified lesion complicated by coronary dissection

Group Type EXPERIMENTAL

Immediate rotational atherectomy (RA)

Intervention Type PROCEDURE

Immediate RA in the treatment with nondilatable calcified lesion complicated by coronary dissection.

Delayed rotational atherectomy (RA)

Delayed RA in the treatment with nondilatable calcified lesion complicated by coronary dissection

Group Type ACTIVE_COMPARATOR

Delayed rotational atherectomy (RA)

Intervention Type PROCEDURE

Delayed RA in the treatment with nondilatable calcified lesion complicated by coronary dissection

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Immediate rotational atherectomy (RA)

Immediate RA in the treatment with nondilatable calcified lesion complicated by coronary dissection.

Intervention Type PROCEDURE

Delayed rotational atherectomy (RA)

Delayed RA in the treatment with nondilatable calcified lesion complicated by coronary dissection

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age between 30 and 85 years old
* nondilatable calcified lesion complicated by coronary dissection during percutaneous coronary intervention (PCI) procedure
* Coronary artery dissection type A, B and type C according to the National Heart, Lung and Blood Institute (NHLBI) coronary dissection criteria

Exclusion Criteria

* acute myocardial infarction
* unprotected left main stenosis
* chronic total occlusion
* saphenous vein graft lesion
* cardiomyopathy
* severe valvular heart disease
* NYHA functional class IV heart failure at baseline
* chronic renal failure on hemodialysis
* severe lung and liver disease or cancer
Minimum Eligible Age

30 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Xijing Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Chengxiang Li, M.D., Ph.D.

Role: PRINCIPAL_INVESTIGATOR

Department of Cardiolody, Xijing Hospital, Fourth Military Medical University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Xijing Hospital, Fourth Military Medical University

Xi'an, Shaanxi, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RAISE

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.